CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-06 | RIEDEL NORBERT G Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | O'Keefe Kenneth W Director | Grant or award | +2,705 | 8,349 | ||
| 2020-08-06 | O'Keefe Kenneth W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | Mulligan Seamus Director | Grant or award | +2,705 | 1,155,493 | ||
| 2020-08-06 | Mulligan Seamus Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | McSharry Heather Ann Director | Grant or award | +2,705 | 11,342 | ||
| 2020-08-06 | McSharry Heather Ann Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | Gray Peter Director | Grant or award | +2,705 | 12,020 | ||
| 2020-08-06 | Gray Peter Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | ENRIGHT PATRICK G Director | Grant or award | +2,705 | 20,368 | ||
| 2020-08-06 | ENRIGHT PATRICK G Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | BERNS PAUL L Director | Grant or award | +2,705 | 10,671 | ||
| 2020-08-06 | BERNS PAUL L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,765 | 6,765 | ||
| 2020-08-06 | Sablich Kim EVP & GM, North America | Grant or award | +16,800 | 16,800 | ||
| 2020-08-06 | Sablich Kim EVP & GM, North America | Grant or award · Incentive Stock Option (right to buy) | +3,144 | 3,144 | ||
| 2020-08-06 | Sablich Kim EVP & GM, North America | Grant or award · Non-Qualified Stock Option (right to buy) | +38,856 | 38,856 | ||
| 2020-08-05 | Patil Neena M SVP, General Counsel | Shares withheld for taxes | −987 | $122.24 | $121K | 19,489 |
| 2020-06-05 | Iannone Robert EVP, Research & Development | Shares withheld for taxes | −943 | $120.65 | $114K | 22,204 |
| 2020-06-05 | Carr Patricia VP, Finance & PAO | Sale | −138 | $124.00 | $17K | 6,500 |
| 2020-05-27 | Mulligan Seamus Director | Purchase | +5,243 | $109.55 | $574K | 1,123,031 |
Page 37 of 39 · 780 trades